NasdaqGS - Nasdaq Real Time Price USD

GoodRx Holdings, Inc. (GDRX)

Time to buy GDRX?

4.3200

+0.0800

+(1.89%)

At close: May 9 at 4:00:02 PM EDT

4.3201

+0.00

+(0.00%)

After hours: May 9 at 7:56:23 PM EDT

Time to buy GDRX?

GoodRx Holdings First Quarter 2025 Earnings: EPS Misses Expectations

GoodRx Holdings ( NASDAQ:GDRX ) First Quarter 2025 Results Key Financial Results Revenue: US$203.0m (up 2.6% from 1Q...

Simply Wall St. 12 hours ago

GDRX
+1.89%
GoodRx Holdings Inc (GDRX) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic ...

GoodRx Holdings Inc (GDRX) reports a 3% revenue increase and outlines strategic growth plans while navigating market uncertainties.

GuruFocus.com yesterday

GDRX
+1.89%
Q1 2025 GoodRx Holdings Inc Earnings Call

Q1 2025 GoodRx Holdings Inc Earnings Call

Thomson Reuters StreetEvents yesterday

GDRX
+1.89%
Why GoodRx Holdings Stock Triumphed on Thursday

The healthcare services specialist unveiled its first set of quarterly results for this year. It beat on both the top and bottom lines, and slightly increased its guidance for a profitability metric. Niche healthcare company GoodRx Holdings (NASDAQ: GDRX) was looking spry and healthy on the stock market Thursday.

Motley Fool 2 days ago

GDRX
+1.89%
GDRX vs. PGNY: Which Stock Should Value Investors Buy Now?

GDRX vs. PGNY: Which Stock Is the Better Value Option?

Zacks 2 days ago

GDRX
+1.89%

PGNY
Is GoodRx (GDRX) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks 2 days ago

GDRX
+1.89%
Compared to Estimates, GoodRx (GDRX) Q1 Earnings: A Look at Key Metrics

Although the revenue and EPS for GoodRx (GDRX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks 3 days ago

GDRX
+1.89%
GoodRx Holdings, Inc. (GDRX) Q1 Earnings Match Estimates

GoodRx (GDRX) delivered earnings and revenue surprises of 0% and 0.19%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 3 days ago

GDRX
+1.89%
GoodRx’s (NASDAQ:GDRX) Q1 Earnings Results: Revenue In Line With Expectations, Stock Jumps 10.3%

Healthcare tech company GoodRx (NASDAQ:GDRX) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 2.6% year on year to $203 million. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $825 million at the midpoint. Its non-GAAP profit of $0.09 per share was in line with analysts’ consensus estimates.

StockStory 3 days ago

GDRX
+1.89%
GoodRx Reports First Quarter 2025 Results

SANTA MONICA, Calif., May 07, 2025--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading platform for medication savings in the U.S., has released its financial results for the first quarter of 2025.

Business Wire 3 days ago

GDRX
+1.89%
GoodRx (GDRX) Reports Earnings Tomorrow: What To Expect

Healthcare tech company GoodRx (NASDAQ:GDRX) will be reporting results tomorrow after the bell. Here’s what you need to know.

StockStory 4 days ago

GDRX
+1.89%
Spotlight On 3 Promising Penny Stocks With Market Caps Over $60M

As the U.S. stock market navigates mixed signals with the S&P 500 and Dow Jones aiming to extend their winning streaks, investors are keenly observing how broader economic factors like interest rates and tariffs might impact future growth. For those willing to explore beyond established giants, penny stocks—often representing smaller or newer companies—continue to hold relevance despite their somewhat outdated moniker. These stocks can offer surprising value when backed by strong financials,...

Simply Wall St. 5 days ago

AGAE

GDRX
+1.89%

SKIN
GoodRx Holdings, Inc. (GDRX) Reports Next Week: Wall Street Expects Earnings Growth

GoodRx (GDRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 10 days ago

GDRX
+1.89%
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

Most readers would already know that GoodRx Holdings' (NASDAQ:GDRX) stock increased by 4.7% over the past week. We...

Simply Wall St. 10 days ago

GDRX
+1.89%
3 Reasons to Sell GDRX and 1 Stock to Buy Instead

GoodRx’s stock price has taken a beating over the past six months, shedding 30.4% of its value and falling to $4.55 per share. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.

StockStory 17 days ago

GDRX
+1.89%
Why GoodRx Holdings (GDRX) Is Among the Best Telehealth Stocks to Buy Now

We recently published a list of 10 Best Telehealth Stocks to Buy Now. In this article, we are going to take a look at where GoodRx Holdings, Inc. (NASDAQ:GDRX) stands against other best telehealth stocks to buy right now. Overview of the American Telehealth Industry According to Grand View Research, the telehealth market size in […]

Insider Monkey 19 days ago

GDRX
+1.89%
3 Healthcare Stocks with Questionable Fundamentals

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 15.5%. This drop was worse than the S&P 500’s 10% fall.

StockStory 22 days ago

LFST

GDRX
+1.89%

DGX
3 of Wall Street’s Favorite Stocks Showing Warning Signs

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

StockStory 23 days ago

FSTR

GDRX
+1.89%

PLUG
GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call

SANTA MONICA, Calif., April 09, 2025--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading platform for medication savings in the U.S., today announced it will release its first quarter 2025 financial results after U.S. markets close on Wednesday, May 7, 2025. GoodRx management will also hold a conference call and webcast the following morning, Thursday, May 8, 2025 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlo

Business Wire last month

GDRX
+1.89%
GoodRx Stock Tumbles Despite Launching New Retail Pharmacy Platform

GDRX rolls out a new e-commerce platform connecting users to top retail pharmacies, aiming to boost savings, improve access, and expand its digital health services.

Zacks last month

GDRX
+1.89%

BSX

CAH

Performance Overview

Return	GDRX	S&P 500 (^GSPC)
YTD	-7.10%	-3.77%
1-Year	-37.66%	+8.55%
3-Year	-59.81%	+41.81%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

GoodRx Holdings, Inc. (GDRX)

GoodRx Holdings First Quarter 2025 Earnings: EPS Misses Expectations

GoodRx Holdings Inc (GDRX) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic ...

Q1 2025 GoodRx Holdings Inc Earnings Call

Why GoodRx Holdings Stock Triumphed on Thursday

GDRX vs. PGNY: Which Stock Should Value Investors Buy Now?

Is GoodRx (GDRX) a Great Value Stock Right Now?

Compared to Estimates, GoodRx (GDRX) Q1 Earnings: A Look at Key Metrics

GoodRx Holdings, Inc. (GDRX) Q1 Earnings Match Estimates

GoodRx’s (NASDAQ:GDRX) Q1 Earnings Results: Revenue In Line With Expectations, Stock Jumps 10.3%

GoodRx Reports First Quarter 2025 Results

GoodRx (GDRX) Reports Earnings Tomorrow: What To Expect

Spotlight On 3 Promising Penny Stocks With Market Caps Over $60M

GoodRx Holdings, Inc. (GDRX) Reports Next Week: Wall Street Expects Earnings Growth

GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

3 Reasons to Sell GDRX and 1 Stock to Buy Instead

Why GoodRx Holdings (GDRX) Is Among the Best Telehealth Stocks to Buy Now

3 Healthcare Stocks with Questionable Fundamentals

3 of Wall Street’s Favorite Stocks Showing Warning Signs

GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call

GoodRx Stock Tumbles Despite Launching New Retail Pharmacy Platform

Performance Overview